Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software

IT & Software

Cellular Biomedicine completes acquisition of Agreen Biotech Cellular Biomedicine Group (CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, has announced it has completed the previously announced acquisition of privately held Agreen Biotech and its founder's US patent.
Automation > IT & Software > News
TherapeuticsMD starts Phase III trial of TX-004HR to treat VVA By PBR Staff Writer
TherapeuticsMD, a US-based women’s healthcare firm, has started patient enrollment in its Phase III clinical trial of TX-004HR (VagiCap) to treat painful intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA), due to menopause.
Automation > IT & Software > News Mymetics' HIV vaccine candidate gets funding to begin study at Texas Biomedical Research Institute Mymetics a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases across mucosal membranes, has announced that its innovative HIV vaccine candidate will enter a new preclinical trial to confirm excellent results obtained in a previous trial.
Automation > IT & Software > News
See more IT & Software news

Latest IT & Software News and Insight

View all IT & Software news or find news targeted to your interests
Adaptimmune secures $104m in series A financing
Adaptimmune Limited, a leading biotechnology company focused on the use of T-cell therapy to treat cancer and infectious disease, has announced the completion of a $104m Series A financing round.
Automation > IT & Software > News
ImmunoCellular, Caltech enter licensing deal for new antigen-specific T-cell technology
By PBR Staff Writer
ImmunoCellular Therapeutics has entered into a licensing agreement with the California Institute of Technology (Caltech) for exclusive rights of new technology to develop certain antigen specific T-cell immunotherapies to treat cancer.
Automation > IT & Software > News
Inovio's Ebola vaccine moving into human trial with GeneOne life science
Inovio Pharmaceuticals has announced that it will advance its DNA vaccine for Ebola into a phase I clinical trial in a collaboration with GeneOne Life Science, an international DNA vaccine manufacturer in which Inovio holds a minority interest.
Automation > IT & Software > News
iCeutica receives key patent for soluMatrix fine particle technology platform
iCeutica has announced that its wholly owned subsidiary has been awarded a key patent for its SoluMatrix Fine Particle Technology platform by the US Patent and Trademark Office (USPTO).
Automation > IT & Software > News
Clinical Ink's eSouce platform selected to power global CNS study
Clinical Ink, an innovation-driven eSource solutions company, has announced that its SureSource platform was selected to capture the critical efficacy data for a global Phase II central nervous system (CNS) study.
Automation > IT & Software > News
Soligenix secures NIAID contract to develop heat stable RiVax vaccine
By PBR Staff Writer
US-based biopharmaceutical firm Soligenix has received a $24.7m contract from the US Department of Health and Human Service's National Institutes of Health (NIH) to develop Heat Stable RiVax vaccine.
Automation > IT & Software > News
biOasis begins MPS II trial with Lysosomal storage disease expert Dr. Maurizio Scarpa and The Brains for Brain Foundation
biOasis Technologies, the pioneering biopharmaceutical company focused on the delivery of therapeutic drugs across the blood-brain barrier (BBB), has announced a study to investigate the ability of its Transcend BBB transport platform technologies to deliver to the Central Nervous System of a knockout animal model, the therapeutic enzyme required to correct the neurological disorder, MPS II, or Hunter Syndrome.
Automation > IT & Software > News
Isis Pharma gets $4m milestone payment from Achaogen for Phase III plazomicin trial
By PBR Staff Writer
Isis Pharmaceuticals has received a $4m milestone payment from Achaogen as part of the start of a Phase III trial of plazomicin to treat patients with serious multi-drug resistant (MDR), gram-negative bacterial infections.
Automation > IT & Software > News
Formpipe receives order from Swiss customer worth SEK1m
Formpipe has recieved an order from a Swiss company through a German reseller regarding the ECM product Lasernet. The product enables effective reporting and streamlined document design directly from Microsoft Dynamics AX 2012. The order value amounts to SEK1m.
Automation > IT & Software > Press Releases
HUYA Bioscience, TIPR form JV for new medical technologies in global markets
By PBR Staff Writer
HUYA Bioscience International (HUYA) has entered into a joint venture agreement with Tianjin Institute of Pharmaceutical Research (TIPR) to develop medical technologies and therapies, originating in both China and the western world, for global markets.
Automation > IT & Software > News
View all IT & Software news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250